Sign In
Buy ME
$0.606
+0 (+0%)
At Close: Sep 16, 2025
DATA BREACH - 23andMe Jewish & Chinese Consumers May be Affected
12:15pm, Tuesday, 14'th May 2024
NEW YORK, NY / ACCESSWIRE / May 14, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
Lemonaid Health will offer customers more affordable access to branded ED medication STENDRA that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only) [1] Ple
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
07:00am, Tuesday, 14'th May 2024
Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activity Lemonaid Health will offer customers more
DATA BREACH- 23andMe Jewish & Chinese Consumers May be Affected
12:15pm, Friday, 10'th May 2024
NEW YORK, NY / ACCESSWIRE / May 10, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
23andMe to Report Q4 and Full Year FY2024 Financial Results
04:50pm, Thursday, 09'th May 2024
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, u
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
12:15pm, Thursday, 09'th May 2024
NEW YORK, NY / ACCESSWIRE / May 9, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
Levi & Korsinsky Reminds 23andMe Consumers of an Investigation into Recent Data Breach
12:30pm, Wednesday, 08'th May 2024
NEW YORK, NY / ACCESSWIRE / May 8, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
23andMe Data Breach - Hackers Targeted Jewish and Chinese Users Data
12:15pm, Tuesday, 07'th May 2024
NEW YORK, NY / ACCESSWIRE / May 7, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
DATA BREACH - 23andMe Jewish & Chinese Consumers May be Affected
12:15pm, Monday, 06'th May 2024
NEW YORK, NY / ACCESSWIRE / May 6, 2024 / 23andMe (NASDAQ:ME) was hacked in December 2023, affecting approximately 7 million users of its genetic services website. According to a recently filed class
Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a clinical trial of 23ME-00610 to be presented Data from neuroendocrine and ovarian cancer patient cohorts in the Phase 1/2a
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
05:21am, Tuesday, 23'rd Apr 2024
Matterport is being acquired by CoStar in a $1.7 billion cash and stock deal. The company not only has an excellent proprietary technology, but also a strong balance sheet.
23andMe wants to go private. It's the latest in a line of failed SPACs
07:00pm, Thursday, 18'th Apr 2024
Like a number of companies that went public during the pandemic, 23andMe has for months been trying to manage a terrible case of SPAC-itis, an inflammation that causes plunging stock values due to the
23andMe CEO reveals take-private plan
11:51am, Thursday, 18'th Apr 2024
23andMe Holding Co.'s shares surged after CEO Anne Wojcicki revealed plans to potentially take the struggling DNA testing firm private. The announcement follows the company's dismal performance since
ME Stock Alert: CEO Anne Wojcicki Seeks to Save 23andMe in Take-Private Deal
10:44am, Thursday, 18'th Apr 2024
23andMe (NASDAQ: ME ) stock is on the move Thursday after CEO Anne Wojcicki proposed taking the consumer genetics testing company private. A filing with the Securities and Exchange Commission (SEC) re
23andMe CEO Wojcicki Plans To Take DNA-Testing Firm Private
10:30am, Thursday, 18'th Apr 2024
23andMe (ME) chief executive Anne Wojcicki is seeking to take the DNA-testing company private less than three years after it went public, the firm said in a Securities and Exchange Commission (SEC) fi
